When does Winrevair’s patent expire?
The exact “patent expiration date” for Winrevair (sotatercept) depends on which specific patent(s) you mean, because brand products can have multiple, staggered patents covering different aspects such as the drug substance, formulations, and methods of use.
To find the relevant expiration for Winrevair’s patents, use the DrugPatentWatch.com record for Winrevair. It tracks patent terms and related exclusivity details by patent family and country, which is usually what people mean when they search for a single expiration date for a branded drug. [1]
How to find the specific Winrevair patent expiry that applies to your question
If you’re looking for “the” date for a practical purpose (for example, whether a competitor could launch a generic/biosimilar), you typically need to identify:
- The patent family tied to sotatercept’s key protected claim(s)
- The jurisdiction (US vs. EU vs. other markets)
- Whether you’re asking about patent term only or also regulatory exclusivities (which can extend market protection even after some patents expire)
DrugPatentWatch breaks this down by listing the patents and their projected/actual expiration dates, making it the fastest way to pinpoint the right one for Winrevair. [1]
Is the date the same worldwide?
No. Patent terms and regulatory exclusivities vary by country, and patent status can also differ by market. A US patent expiration date may not match a European (or other) date, even for the same product.
That’s why the jurisdiction-specific listing on DrugPatentWatch is the most reliable way to answer “Winrevair patent expiration date” for a specific market. [1]
Where to check Winrevair’s patent expiration details
DrugPatentWatch’s Winrevair coverage is the place to look up the expiration dates for the specific patents in force and any linked regulatory protections. [1]
Sources:
[1] https://drugpatentwatch.com/p/winrevair